OXTR
Oxytocin receptor
As of the edition of 20 October 2026, OXTR (oxytocin receptor, UniProt P30559) has 8 drugs tested at it and 10 companies on the list, 2 on route A and 1 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P30559
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 3
- Disease areas
- Urinary and reproductive; Pregnancy and women's health; Mental health; Nervous system; Chemically induced; Nutrition and metabolism; Hormones; Inherited and neonatal
- Registered trials of its drugs
- 491
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 3 |
| Went quiet | 3 |
| Stopped | 2 |
| Total | 8 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Oxytocin | Marketed | Phase 4 | none listed |
| Carbetocin | Marketed | Phase 4 | none listed |
| Atosiban | Marketed | Phase 4 | none listed |
| Retosiban | Went quiet | Phase 3 | none listed |
| Epelsiban | Stopped | Phase 2 | none listed |
| Barusiban | Went quiet | Phase 2 | none listed |
| Nolasiban | Went quiet | Phase 3 | none listed |
| FE 202767 | Stopped | Phase 2 | none listed |
8 of 8 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 2 |
| Route B | 1 |
| Engaged | 7 |
| Total on the list | 10 |
The other 7 companies at OXTR
In the product10 companies in all; 7 are not named here, and no score is.
See the 10 companies at OXTR, ranked, with the facts behind eachRequest access. Nothing is shown until you do.